Smith Cynthia
Insider CIK 1609480 · TVRD Director · TARA Director · DRNA Director · AGIO Director · ZSPH See Remarks · AKBA Director · SPRO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2026-06-23 | 2026-06-25 | 20,000 | — | $0 | 20,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2026-06-23 | 2026-06-25 | 10,000 | — | $0 | 85,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 2,927 | — | $0 | 2,927 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2026-06-18 | 2026-06-23 | 14,950 | — | $0 | 14,950 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2026-06-18 | 2026-06-23 | 2,816 | — | $0 | 15,230 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2026-06-17 | 2026-06-22 | 53,600 | — | $0 | 53,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2026-06-17 | 2026-06-22 | 35,700 | — | $0 | 196,633 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2026-06-15 | 2026-06-16 | 31,000 | — | $0 | 31,000 | SEC↗ |
| TVRD Tvardi Therapeutics, Inc. | A Award deriv | 2026-06-09 | 2026-06-11 | 6,000 | — | $0 | 6,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-08-11 | 2025-08-13 | 2,302 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-08-11 | 2025-08-13 | 2,302 | — | $0 | 12,414 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2025-06-20 | 2025-06-23 | 2,120 | — | $0 | 10,112 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-06-18 | 2025-06-23 | 15,768 | — | $0 | 15,768 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2025-06-18 | 2025-06-23 | 2,816 | — | $0 | 2,816 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2025-06-12 | 2025-06-13 | 24,000 | — | $0 | 24,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2025-06-12 | 2025-06-16 | 20,000 | — | $0 | 75,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2025-06-10 | 2025-06-11 | 53,600 | — | $0 | 53,600 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2025-06-10 | 2025-06-11 | 35,700 | — | $0 | 160,933 | SEC↗ |
| TVRD Tvardi Therapeutics, Inc. | A Award deriv | 2025-04-17 | 2025-04-21 | 12,000 | — | $0 | 12,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-08-11 | 2024-08-13 | 2,302 | — | $0 | 2,302 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-08-11 | 2024-08-13 | 2,302 | — | $0 | 7,992 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-06-20 | 2024-06-24 | 11,774 | — | $0 | 11,774 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2024-06-20 | 2024-06-24 | 2,120 | — | $0 | 2,120 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2024-06-13 | 2024-06-17 | 3,388 | — | $0 | 0 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2024-06-13 | 2024-06-17 | 3,388 | — | $0 | 5,690 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2024-06-07 | 2024-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2024-06-06 | 2024-06-10 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2024-06-06 | 2024-06-10 | 30,000 | — | $0 | 125,233 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2024-05-29 | 2024-05-30 | 20,000 | — | $0 | 55,000 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2023-10-05 | 2023-10-10 | 20,000 | — | $0 | 35,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise deriv | 2023-08-11 | 2023-08-15 | 2,302 | — | $0 | 4,604 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | M Exercise | 2023-08-11 | 2023-08-15 | 2,302 | — | $0 | 2,302 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-06-13 | 2023-06-15 | 18,958 | — | $0 | 18,958 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2023-06-13 | 2023-06-15 | 3,388 | — | $0 | 3,388 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2023-06-07 | 2023-06-08 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 45,000 | — | $0 | 45,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2023-06-06 | 2023-06-08 | 30,000 | — | $0 | 95,233 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award | 2022-09-15 | 2022-09-19 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-08-11 | 2022-08-15 | 6,906 | — | $0 | 6,906 | SEC↗ |
| AGIO AGIOS PHARMACEUTICALS, INC | A Award deriv | 2022-08-11 | 2022-08-15 | 37,947 | — | $0 | 37,947 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2022-06-08 | 2022-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2022-06-08 | 2022-06-09 | 13,700 | — | $0 | 65,233 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 3,333 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 25,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | D To issuer deriv | 2021-12-28 | 2021-12-29 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | U Tender | 2021-12-28 | 2021-12-29 | 3,333 | $38.25 | $127.5K | 0 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-08-17 | 2021-08-18 | 7,500 | — | $0 | 7,500 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2021-06-09 | 2021-06-10 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2021-06-03 | 2021-06-07 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2021-06-03 | 2021-06-07 | 3,333 | — | $0 | 3,333 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2021-06-02 | 2021-06-03 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2021-06-02 | 2021-06-03 | 13,700 | — | $0 | 51,533 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2021-01-29 | 2021-02-01 | 18,000 | — | $0 | 18,000 | SEC↗ |
| TARA Protara Therapeutics, Inc. | A Award deriv | 2021-01-29 | 2021-02-01 | 3,750 | — | $0 | 21,750 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2021-01-04 | 2021-01-06 | 2,629 | $13.31 | $35.0K | 2,629 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2020-10-27 | 2020-10-27 | 7,500 | — | $0 | 7,500 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-06-15 | 2020-06-16 | 3,333 | — | $0 | 3,333 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2020-06-15 | 2020-06-16 | 15,000 | — | $0 | 15,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | S Sale | 2020-06-08 | 2020-06-09 | 4,567 | $12.10 | $55.3K | 37,833 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2020-06-05 | 2020-06-09 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2020-06-05 | 2020-06-09 | 13,700 | — | $0 | 42,400 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | P Buy | 2019-11-20 | 2019-11-22 | 15,000 | $3.52 | $52.8K | 28,700 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2019-06-20 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 20,100 | — | $0 | 20,100 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award | 2019-06-06 | 2019-06-10 | 13,700 | — | $0 | 13,700 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2019-06-05 | 2019-06-05 | 6,073 | — | $0 | 6,073 | SEC↗ |
| SPRO Spero Therapeutics, Inc. | A Award deriv | 2019-03-29 | 2019-03-29 | 12,146 | — | $0 | 12,146 | SEC↗ |
| AKBA Akebia Therapeutics, Inc. | A Award deriv | 2018-08-28 | 2018-08-29 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2018-08-13 | 2018-08-15 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 5,504 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 185,230 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 20,520 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 15,076 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 1,799 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 30,246 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer deriv | 2015-12-17 | 2015-12-21 | 2,791 | — | $0 | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | D To issuer | 2015-12-17 | 2015-12-21 | 12,598 | $90.00 | $1.13M | 0 | SEC↗ |
| ZSPH ZS Pharma, Inc. | M Exercise deriv | 2015-12-08 | 2015-12-10 | 9,155 | — | $0 | 20,520 | SEC↗ |
| ZSPH ZS Pharma, Inc. | M Exercise | 2015-12-08 | 2015-12-10 | 9,155 | $10.92 | $100.0K | 9,155 | SEC↗ |
| ZSPH ZS Pharma, Inc. | A Award deriv | 2015-06-18 | 2015-06-25 | 3,000 | — | $0 | 3,000 | SEC↗ |
| ZSPH ZS Pharma, Inc. | A Award deriv | 2015-06-18 | 2015-06-25 | 16,875 | $55.57 | $937.7K | 16,875 | SEC↗ |
| ZSPH ZS Pharma, Inc. | A Award deriv | 2014-07-08 | 2014-07-10 | 33,037 | — | $0 | 33,037 | SEC↗ |